STALLERGENES GREER |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
+0.14% | +29.68% |
| 2023 | Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes | CI |
| 2023 | Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 0 | - | - | - | - | - | |
| 79.03B | ||||||
| 8.78B | ||||||
| 4.83B | ||||||
| 4.65B | - | - | ||||
| 3.89B |
- Stock Market
- Equities
- STAGR Stock
- Charts Stallergenes Greer
- Sector Chart
